Second Russian virus vaccine passes early trials: report

Early clinical trials of a second Russian coronavirus vaccine have proved successful, its developer said Thursday after Russia boasted of approving the world’s first vaccine.

Russia’s Vektor — a top-secret state virology research centre in Siberia — said that early-stage trials were successful for its own experimental vaccine, named EpiVacCorona.

“The first two phases of clinical trials demonstrated the effectiveness and safety of the EpiVacCorona vaccine,” Vektor’s press department told the Interfax news agency.

Russia announced in August that it had developed the world’s first registered vaccine — named “Sputnik V” after the world’s first satellite.

It raised concerns among Western scientists by announcing that the vaccine — developed by Moscow’s Gamaleya research centre — had received approval before full clinical trials have been completed.

Vektor said it would be possible to make the final conclusions about the efficacy of its vaccine, based on peptides that trigger an immune response, after post-approval clinical trials have been completed.

Russian Health Minister Mikhail Murashko told President Vladimir Putin this week that Vektor’s vaccine could be approved by the ministry in three weeks.

Vektor said post-registration clinical trials would begin on 5,000 volunteers in Siberia.

The lab said there would be a separate clinical trial involving 150 volunteers who are over 60 years of age.

After that Vektor will begin placebo-controlled trials on 5,000 Russian volunteers between the ages of 18 and 60.

The EpiVacCorona vaccine is a two-component vaccine, and the interval between the administration of the first and second components is 21 days.

Russia plans to manufacture an initial 10,000 doses, Vektor said, with production expected to begin in November.

Vektor declined to comment when contacted by AFP and referred all queries to Rospotrebnadzor, the country’s consumer safety watchdog.

The watchdog declined immediate comment.

The Vektor laboratory complex conducted secret biological weapons research in the Soviet era and stockpiles viruses ranging from Ebola to smallpox. It is located outside the Siberian city of Novosibirsk.

  • Related Posts

    NAFDAC Uncovers Expired Baby Diapers, Balms, Others In Lagos

      The National Agency for Food and Drug Administration and Control (NAFDAC) says it has uncovered expired baby diapers, methylated balms, and other regulated products in a store at Idumota,…

    NAFDAC uncovers N500m fake alcohol factory in Aba

      The National Agency for Food and Drug Administration and Control has uncovered a suspected counterfeit alcoholic beverage production facility in Aba, Abia State, with equipment and materials found at…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nigerian Man Sentenced to 24 Months in US for Aggravated Identity Theft

    • By admin
    • November 21, 2026
    • 2 views
    Nigerian Man Sentenced to 24 Months in US for Aggravated Identity Theft

    Terrorists bomb high voltage lines linking Kainji Dam to Jebba

    • By admin
    • November 21, 2026
    • 4 views
    Terrorists bomb high voltage lines linking Kainji Dam to Jebba

    Mexico arrests FBI most-wanted drug lord Chapo Isidro

    • By admin
    • November 21, 2026
    • 9 views
    Mexico arrests FBI most-wanted drug lord Chapo Isidro

    NCoS releases names, photos of two fleeing death-row inmates in Kwara

    • By admin
    • November 21, 2026
    • 10 views
    NCoS releases names, photos of two fleeing death-row inmates in Kwara

    Police Recover Bodies Of Two Abducted Victims In Edo

    • By admin
    • November 21, 2026
    • 5 views
    Police Recover Bodies Of Two Abducted Victims In Edo

    Imo police hunt man for killing girlfriend

    • By admin
    • November 21, 2026
    • 6 views
    Imo police hunt man for killing girlfriend